{"id":"https://openalex.org/W4388871663","doi":"https://doi.org/10.1016/j.phrs.2023.107005","title":"The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation","display_name":"The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation","alternate_titles":[],"publication_year":2023,"publication_date":"2023-11-21","ids":{"openalex":"https://openalex.org/W4388871663","doi":"https://doi.org/10.1016/j.phrs.2023.107005","pmid":"https://pubmed.ncbi.nlm.nih.gov/37992916"},"language":"en","primary_location":{"id":"doi:10.1016/j.phrs.2023.107005","doi":"https://doi.org/10.1016/j.phrs.2023.107005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2023.107005","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4388871663"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.phrs.2023.107005","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100665521","display_name":"Jianmin Chen","orcid":"https://orcid.org/0000-0003-0098-0857","observed_orcids":["https://orcid.org/0000-0003-0098-0857"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jianmin Chen","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]},{"raw_affiliation_string":"Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053906761","display_name":"Silvia Oggero","orcid":"https://orcid.org/0000-0003-1451-3870","observed_orcids":["https://orcid.org/0000-0003-1451-3870"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Silvia Oggero","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086829409","display_name":"Chiara Cecconello","orcid":"https://orcid.org/0009-0002-8469-4072","observed_orcids":["https://orcid.org/0009-0002-8469-4072"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chiara Cecconello","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061453586","display_name":"Jesmond Dalli","orcid":"https://orcid.org/0000-0001-6328-3640","observed_orcids":["https://orcid.org/0000-0001-6328-3640"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jesmond Dalli","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]},{"raw_affiliation_string":"Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074412807","display_name":"Hedayatullah Hayat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hedayatullah Hayat","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093310058","display_name":"Ahmad Hjiej Andaloussi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ahmad Hjiej Andaloussi","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047698603","display_name":"Samra Joke Sanni","orcid":"https://orcid.org/0000-0002-9708-5674","observed_orcids":["https://orcid.org/0000-0002-9708-5674"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samra Sanni","raw_affiliation_strings":["ResoTher Pharma A/S, Holte, Denmark","ResoTher Pharma APs, Holte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ResoTher Pharma A/S, Holte, Denmark","institution_ids":[]},{"raw_affiliation_string":"ResoTher Pharma APs, Holte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108227467","display_name":"Thomas E. N. Jonassen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas EN Jonassen","raw_affiliation_strings":["ResoTher Pharma A/S, Holte, Denmark","ResoTher Pharma APs, Holte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ResoTher Pharma A/S, Holte, Denmark","institution_ids":[]},{"raw_affiliation_string":"ResoTher Pharma APs, Holte, Denmark","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016097947","display_name":"Mauro Perretti","orcid":"https://orcid.org/0000-0003-2068-3331","observed_orcids":["https://orcid.org/0000-0003-2068-3331"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210149920","display_name":"William Harvey Research Institute","ror":"https://ror.org/0574dzy90","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4210149920"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mauro Perretti","raw_affiliation_strings":["William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom. Electronic address: m.perretti@qmul.ac.uk","Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom. Electronic address: m.perretti@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]},{"raw_affiliation_string":"Centre for inflammation and Therapeutic Innovation, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":"William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016097947","https://openalex.org/A5053906761"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4210149920"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":4.2223,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.95541711,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"198","issue":null,"first_page":"107005","last_page":"107005"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.8276000022888184,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.8276000022888184,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.11479999870061874,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12030","display_name":"S100 Proteins and Annexins","score":0.01360000018030405,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/annexin-a1","display_name":"annexin A1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/acute-myocardial-infarction","display_name":"acute myocardial infarction","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.9459999799728394},{"id":"https://openalex.org/keywords/neutrophil-activation","display_name":"neutrophil activation","score":0.8019999861717224},{"id":"https://openalex.org/keywords/monocyte-recruitment","display_name":"monocyte recruitment","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cardiac-inflammation","display_name":"cardiac inflammation","score":0.5090000033378601},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.8320000171661377},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.8429999947547913},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.7310000061988831},{"id":"https://openalex.org/keywords/vascular-inflammation","display_name":"vascular inflammation","score":0.44699999690055847},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C2779676291","wikidata":"https://www.wikidata.org/wiki/Q25325349","display_name":"Cardioprotection","level":3,"score":0.67937833070755},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5670843720436096},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5121214389801025},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49085360765457153},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.4735890030860901},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.45899561047554016},{"id":"https://openalex.org/C2780114680","wikidata":"https://www.wikidata.org/wiki/Q1413991","display_name":"Reperfusion injury","level":3,"score":0.4488532543182373},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.4421998858451843},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4299486577510834},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40167200565338135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3175957500934601},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31320762634277344},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.20586317777633667},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.18777307868003845}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017305","descriptor_name":"Annexin A1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.phrs.2023.107005","doi":"https://doi.org/10.1016/j.phrs.2023.107005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2023.107005","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},{"id":"pmid:37992916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37992916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological research","raw_type":"Journal Article"},{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/92298","doi":null,"is_oa":true,"landing_page_url":"https://qmro.qmul.ac.uk/xmlui/handle/123456789/92298","pdf_url":"https://qmro.qmul.ac.uk/xmlui/bitstream/123456789/92298/2/Chen%20The%20Annexin-A1%20mimetic%20RTP026%20promotes%20acute%20cardioprotection%20through%20modulation%20of%20immune%20cell%20activation%202023%20Accepted.pdf","source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:24ec03362e644c72af881404e8bf20c2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/24ec03362e644c72af881404e8bf20c2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacological Research, Vol 198, Iss , Pp 107005- (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.phrs.2023.107005","doi":"https://doi.org/10.1016/j.phrs.2023.107005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2023.107005","pdf_url":null,"source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3631329761","display_name":"Establishing the molecular fundamentals of arthritic diseases \u2013 a step forward to Heal Arthritis","funder_award_id":"812890","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G399670327","display_name":null,"funder_award_id":"22855","funder_id":"https://openalex.org/F4320327444","funder_display_name":"Versus Arthritis"},{"id":"https://openalex.org/G8810176120","display_name":null,"funder_award_id":"MGU0489","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"}],"funders":[{"id":"https://openalex.org/F4320315977","display_name":"Barts Charity","ror":"https://ror.org/0513pp416"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320327444","display_name":"Versus Arthritis","ror":"https://ror.org/02jkpm469"},{"id":"https://openalex.org/F4320332999","display_name":"Horizon 2020 Framework Programme","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320338337","display_name":"H2020 Marie Sk\u0142odowska-Curie Actions","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388871663.pdf","grobid_xml":"https://content.openalex.org/works/W4388871663.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W1483031894","https://openalex.org/W1503364336","https://openalex.org/W1549749341","https://openalex.org/W1577698567","https://openalex.org/W1856034726","https://openalex.org/W1922367465","https://openalex.org/W1968666896","https://openalex.org/W1978453991","https://openalex.org/W1978995782","https://openalex.org/W1982283061","https://openalex.org/W1984917583","https://openalex.org/W1992467867","https://openalex.org/W1996079126","https://openalex.org/W2002330080","https://openalex.org/W2009263722","https://openalex.org/W2014462125","https://openalex.org/W2015141049","https://openalex.org/W2025601067","https://openalex.org/W2034719543","https://openalex.org/W2036439732","https://openalex.org/W2043731021","https://openalex.org/W2065639597","https://openalex.org/W2069091008","https://openalex.org/W2069186231","https://openalex.org/W2102772338","https://openalex.org/W2104279524","https://openalex.org/W2108095498","https://openalex.org/W2124502562","https://openalex.org/W2128141580","https://openalex.org/W2133496985","https://openalex.org/W2145051756","https://openalex.org/W2153095652","https://openalex.org/W2267597338","https://openalex.org/W2462460222","https://openalex.org/W2568405604","https://openalex.org/W2587567454","https://openalex.org/W2597925028","https://openalex.org/W2605756095","https://openalex.org/W2742246935","https://openalex.org/W2743547103","https://openalex.org/W2748400555","https://openalex.org/W2802901067","https://openalex.org/W2920248606","https://openalex.org/W2949648051","https://openalex.org/W3004663884","https://openalex.org/W3006212196","https://openalex.org/W3009993886","https://openalex.org/W3045067389","https://openalex.org/W3087013339","https://openalex.org/W3193843934","https://openalex.org/W4214660805","https://openalex.org/W4224145842","https://openalex.org/W4284681524","https://openalex.org/W4297038070","https://openalex.org/W6774851129"],"related_works":["https://openalex.org/W2036439732","https://openalex.org/W2927520682","https://openalex.org/W1151550657","https://openalex.org/W7061724254","https://openalex.org/W2145051756","https://openalex.org/W1992467867","https://openalex.org/W2076082685","https://openalex.org/W2075644026","https://openalex.org/W588783613","https://openalex.org/W1549749341"],"abstract_inverted_index":{"The":[0,87],"cardio-protective":[1],"and":[2,55,79,85,96,141,159,164,187,202,216],"immuno-regulatory":[3],"properties":[4],"of":[5,28,52,58,69,117,132,157,168,180,220,241],"RTP-026,":[6],"a":[7,234],"synthetic":[8],"peptide":[9],"that":[10,137],"spans":[11],"the":[12,41,105,115,146,150,190,221,239],"Annexin-A1":[13],"(AnxA1)":[14],"N-terminal":[15],"region,":[16],"were":[17],"tested":[18],"in":[19,40,66,83,177,223],"rat":[20,70,88],"acute":[21,71],"myocardial":[22],"infarction.":[23],"In":[24,149],"vitro,":[25],"selective":[26],"activation":[27,156,230],"formyl-peptide":[29],"receptor":[30],"type":[31],"2":[32],"(FPR2)":[33],"by":[34,61,123,171,175,209,231],"RTP-026":[35,49,109,138,152,172,194,211,232],"occurred":[36],"with":[37,125],"apparent":[38],"EC50":[39],"10-30":[42],"nM":[43],"range.":[44],"With":[45],"human":[46],"primary":[47],"cells,":[48],"counteracted":[50],"extension":[51],"neutrophil":[53,140],"life-span":[54],"augmented":[56],"phagocytosis":[57],"fluorescent":[59],"E.coli":[60],"blood":[62],"myeloid":[63],"cells.":[64],"An":[65],"vivo":[67],"model":[68],"infarction":[72],"was":[73,94,173],"used":[74],"to":[75,145,237],"quantify":[76],"tissue":[77],"injury":[78],"phenotype":[80],"immune":[81,134,213,228],"cells":[82,135],"myocardium":[84,208],"blood.":[86],"left":[89],"anterior":[90],"descending":[91],"coronary":[92],"artery":[93],"occluded":[95],"then":[97],"reopened":[98],"for":[99,243],"2-hour":[100,106],"or":[101],"24-hour":[102,191],"reperfusion.":[103],"For":[104,189],"reperfusion":[107,192],"protocol,":[108,193],"(25-500":[110],"\u00b5g/kg;":[111],"given":[112,197],"i.v.":[113,198],"at":[114,128,199],"start":[116],"reperfusion)":[118,205],"significantly":[119],"reduced":[120,139,206],"infarct":[121,218],"size":[122,219],"~50%,":[124],"maximal":[126],"efficacy":[127],"50":[129],"\u00b5g/kg.":[130],"Analyses":[131],"cardiac":[133],"showed":[136],"classical":[142],"monocyte":[143],"recruitment":[144],"damaged":[147],"heart.":[148],"blood,":[151],"(50":[153],"\u00b5g/kg)":[154],"attenuated":[155],"neutrophils":[158],"monocytes":[160],"monitored":[161],"through":[162],"CD62L":[163],"CD54":[165],"expression.":[166],"Modulation":[167],"vascular":[169],"inflammation":[170],"demonstrated":[174],"reduction":[176],"plasma":[178],"levels":[179],"mediators":[181],"like":[182],"TNF-\u03b1,":[183],"IL-1\u03b2,":[184],"KC,":[185],"PGE2":[186],"PGF2\u03b1\u22a1":[188],"(30":[195],"\u00b5g/kg":[196],"0,":[200],"3":[201],"6":[203],"hours":[204],"necrotic":[207],"~40%.":[210],"modulate":[212],"cell":[214,229],"responses":[215],"decreases":[217],"heart":[222],"preclinical":[224],"settings.":[225],"Tempering":[226],"over-exuberant":[227],"is":[233],"suitable":[235],"approach":[236],"translate":[238],"biology":[240],"AnxA1":[242],"therapeutic":[244],"purposes.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4388871663","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2023-11-22T00:00:00"}
